Clinical trials
Hypertension trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
320 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 9 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 9 |
| 2013 | 11 |
| 2014 | 13 |
| 2015 | 16 |
| 2016 | 16 |
| 2017 | 17 |
| 2018 | 19 |
| 2019 | 27 |
| 2020 | 26 |
| 2021 | 23 |
| 2022 | 38 |
| 2023 | 40 |
| 2024 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 320 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Instituto de Cardiologia do Rio Grande do Sul | 6 |
| Brigham and Women's Hospital | 5 |
| Aga Khan University | 4 |
| China National Center for Cardiovascular Diseases | 4 |
| Beijing Anzhen Hospital | 3 |
| Beijing Sport University | 3 |
| Cairo University | 3 |
| Charite University, Berlin, Germany | 3 |
| Chinese University of Hong Kong | 3 |
| Duke-NUS Graduate Medical School | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 320 |
| Diabetes Mellitus | 47 |
| Obesity | 35 |
| Cardiovascular Diseases | 34 |
| Diabetes Mellitus, Type 2 | 27 |
| Dyslipidemias | 20 |
| Hyperlipidemias | 15 |
| Metabolic Syndrome | 15 |
| Essential Hypertension | 10 |
| Hypercholesterolemia | 10 |
Trials
Showing 1 to 25 of 320. Each trial links to its page on Pharma Observatory.
220 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.